Medical Condition News

RSS

Taste receptors in lungs can revolutionize treatment option for asthma

Taste receptors in the lungs. Researchers at the University of Maryland School of Medicine in Baltimore have discovered that bitter taste receptors are not just located in the mouth but also in human lungs. What they learned about the role of the receptors could revolutionize the treatment of asthma and other obstructive lung diseases.

25 Oct 2010

Researchers discover microglia cells originates prior to birth during embryonic life

Mount Sinai researchers have discovered that microglia, the immune cells that reside in the brain, have a unique origin and are formed shortly after conception. It was previously thought that microglia originated at the same time as macrophages, which are other immune cells that are thought to develop at birth. This groundbreaking discovery has the potential to lead to future treatments of degenerative brain diseases such as Alzheimer's and autoimmune diseases such as multiple sclerosis. The study is published online October 21 in Science Express.

25 Oct 2010

WallFlex Biliary RX Stent receives CE Mark approval for benign biliary strictures

Boston Scientific Corporation today announced that its WallFlex Biliary RX Fully Covered Stent has received CE Mark approval for the treatment of benign biliary strictures.

25 Oct 2010

$Cedars-Sinai to develop world's first biological treatment for compression fractures$

Cedars-Sinai to develop world's first biological treatment for compression fractures

A team of physicians and scientists from the Cedars-Sinai Regenerative Medicine Institute and Department of Surgery, led by Dan Gazit, DMD, PhD has been awarded a three-year $1.9 million grant from the California stem cell agency to fund research leading to clinical trials for what could become the first biological treatment for the most common type of bone fracture in osteoporosis patients.

25 Oct 2010

Pharmaxis announces combined results of Bronchitol Phase III trial for cystic fibrosis

Pharmaceutical company Pharmaxis today announced significant results of pooled data from its two large scale six month Phase III trials of Bronchitol (inhaled mannitol) in people with cystic fibrosis.

25 Oct 2010

ISTSS to honor Vietnam veteran with Lifetime Achievement Award

Joseph Boscarino, Ph.D, M.P.H.,will be recognized by the International Society of Traumatic Stress (ISTSS) with a Lifetime Achievement Award for his contributions to the research of traumatic stress.

25 Oct 2010

Scientists find two proteins that regulates water retention in salt-sensitive hypertension

Research conducted by scientists at LSU Health Sciences Center New Orleans has found that two proteins in the brain act as valves to turn the hormone that regulates water retention in the body on and off. Their findings may lead to advances in treatment for diseases like high blood pressure, congestive heart failure, and cirrhosis of the liver. The research is published in the November 1, 2010 issue of Endocrinology.

25 Oct 2010

72% of patients misdiagnosed with pneumonia upon readmission : Study

Patients were misdiagnosed with pneumonia at an alarming rate when they were readmitted to the hospital shortly after a previous hospitalization for the same illness, according to two Henry Ford Hospital companion studies.

25 Oct 2010

UCSF scientists receive grants to refine embryonic stem cell-based strategies for neurological diseases

UCSF scientists have received two grants from the California Institutefor Regenerative Medicine to refine their human embryonic stem cell-based strategies for treating neurological diseases and liver failure. The goal of the grants is for researchers to make significant strides toward the development of potential therapies within the next three years.

25 Oct 2010

New annual campaign to prevent skin cancer

The annual "Euromelanoma Day" campaign is designed to prevent skin cancer among the general public. While there has been considerable interest, it has proved difficult to reach out to some of the at-risk groups. As such, new ways of encouraging these people to go to a dermatologist are being introduced, reveals research from the University of Gothenburg presented at the dermatologist conference in Sweden.

25 Oct 2010

ASD-related health care expenditures escalate in state Medicaid programs

Autism was described as early as 1940, but a marked increase in the prevalence for the broader class of autism spectrum disorders (ASDs) during the past decade highlights the demand for treatment of affected individuals. The Centers for Disease Control and Prevention (CDC) reported that the prevalence of ASD was one in 110 children in 2006 and increased at an average annual rate of 57% between 2002 and 2006. The rising prevalence has heightened concern about the financial impact of treating ASDs in the private and public health care systems.

25 Oct 2010

Arena's NDA receives Complete Response Letter for lorcaserin

Arena Pharmaceuticals, Inc. and Eisai Inc. announced that the US Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding Arena's New Drug Application (NDA) for lorcaserin. Lorcaserin is intended for weight management, including weight loss and maintenance of weight loss, in patients who are obese

25 Oct 2010

Valvoline stores raises funds to fight prostate cancer

Several area Valvoline Instant Oil Change service centers are not only changing the oil in cars, but they're also asking customers to consider changing the way they contribute to the fight against prostate cancer.

25 Oct 2010

Diabetes on the rise in Scotland

New reports show that one person is diagnosed with diabetes every 40 minutes in Scotland. This marks the rapid rise in the condition - a trend that is faster that experts had imagined. In the last 1 year another 14,000 Scots were added to those registered with GPs as diabetic.

24 Oct 2010

New ear implant for Meniere’s disease

Meniere’s disease is a disease that affects the inner ear – a region responsible for balance. It affects 1% of Americans and can be quite disabling since it leads to attacks of vertigo. At present medications can not completely cure the condition and surgery is often unsuccessful.

24 Oct 2010

Intestinal microbiota can increase broccoli’s cancer-preventive power: Research

A University of Illinois study has shown for the first time that sulforaphane, the powerful cancer-fighting agent in broccoli, can be released from its parent compound by bacteria in the lower gut and absorbed into the body.

22 Oct 2010

Research could lead to new therapies for breast cancers

WORK by scientists in Australia could open the door to a new way of treating certain breast cancers. The disease is now the most common cancer in the UK, with around 125 women in the country diagnosed every day.

22 Oct 2010

Researchers use fruit fly for cancer research

SMALL and with a life cycle of just two weeks, fruit flies are seen by many as pests and a problem all year round. However, for nearly a century, the humble insect, officially known as Drosophila melanogaster, which measures no more than 3mm, has performed a vital role in genetics and developmental biology.Fruit flies are genetically diverse and easy to use in research, helping scientists in a variety of studies, from how the brain functions to how cancer develops.

22 Oct 2010

Bright Starts announces 2010 Pink Power Mom winners

In an ongoing effort to support breast cancer awareness, education and research, Bright Starts announces the winners of its fourth annual Pink Power Mom search. The winners are eight inspirational mothers who have survived (or are currently battling) breast cancer and have used their experience to make a profound difference in the lives of other women affected by the disease

22 Oct 2010

New assessment tool to measure cognitive representation of chronic disease

What do we mean by "common sense" when we talk about a disease? What affects the ideas and beliefs that patients have of their disease. Researchers at the University of Granada have developed a test for measuring and assessing chronic patients' cognitive representation of their disease. This advance will enable the development of clinical psychological treatments much more efficient than those currently employed.

22 Oct 2010